{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:03:27Z","timestamp":1770681807550,"version":"3.49.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T00:00:00Z","timestamp":1742774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T00:00:00Z","timestamp":1742774400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Natural Science Foundation project of Anhui Province","award":["2308085QH290"],"award-info":[{"award-number":["2308085QH290"]}]},{"name":"Key Project of Natural Science Research Project of Universities in Anhui Province","award":["2024AH050984"],"award-info":[{"award-number":["2024AH050984"]}]},{"name":"High-level talent support plan of Anhui university of Chinese medicine","award":["DT2300000270"],"award-info":[{"award-number":["DT2300000270"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-025-01899-z","type":"journal-article","created":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T03:19:32Z","timestamp":1742786372000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Wilson disease combined with polycystic ovary syndrome\u2013clinical features, treatment, and outcome in Chinese patients"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-9449-2876","authenticated-orcid":false,"given":"Lin","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-juan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang-liang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-feng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-zhu","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu-en","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3123-5617","authenticated-orcid":false,"given":"Yin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,24]]},"reference":[{"key":"1899_CR1","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ncl.2020.01.005","volume":"38","author":"C Mulligan","year":"2020","unstructured":"Mulligan C, Bronstein JM. Wilson disease: an overview and approach to management. Neurol Clin. 2020;38:417\u201332.","journal-title":"Neurol Clin"},{"key":"1899_CR2","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jhep.2011.11.007","volume":"56","author":"European Association for Study of Liver","year":"2012","unstructured":"European Association for Study of Liver. EASL clinical practice guidelines: Wilson\u2019s disease. J Hepatol. 2012;56:671\u201385.","journal-title":"J Hepatol"},{"key":"1899_CR3","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/hep.30911","volume":"71","author":"TD Sandahl","year":"2020","unstructured":"Sandahl TD, Laursen TL, Munk DE, Vilstrup H, Weiss KH, Ott P. The prevalence of Wilson\u2019s disease: an update. Hepatology. 2020;71:722\u201332.","journal-title":"Hepatology"},{"issue":"Suppl 2","key":"1899_CR4","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.21037\/atm.2019.02.10","volume":"7","author":"A Poujois","year":"2019","unstructured":"Poujois A, Woimant F. Challenges in the diagnosis of Wilson disease. Ann Transl Med. 2019;7(Suppl 2):S67.","journal-title":"Ann Transl Med"},{"key":"1899_CR5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","volume":"106","author":"D Lizneva","year":"2016","unstructured":"Lizneva D, Suturina L, Walker W, Brakta S, Gavrilova-Jordan L, Azziz R. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril. 2016;106:6\u201315.","journal-title":"Fertil Steril"},{"key":"1899_CR6","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMcp1514916","volume":"375","author":"CR McCartney","year":"2016","unstructured":"McCartney CR, Marshall JC. Polycystic ovary syndrome. N Engl J Med. 2016;375:54\u201364.","journal-title":"N Engl J Med"},{"key":"1899_CR7","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMcp1514916","volume":"375","author":"CR McCartney","year":"2016","unstructured":"McCartney CR, Marshall JC. Clinical Practice. Polycystic ovary syndrome. N Engl J Med. 2016;375:54\u201364.","journal-title":"N Engl J Med"},{"key":"1899_CR8","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.cnur.2018.04.008","volume":"53","author":"RK Meier","year":"2018","unstructured":"Meier RK. Polycystic ovary syndrome. Nurs Clin North Am. 2018;53:407\u201320.","journal-title":"Nurs Clin North Am"},{"key":"1899_CR9","doi-asserted-by":"crossref","first-page":"855","DOI":"10.4103\/2230-8210.141383","volume":"18","author":"N Kapoor","year":"2014","unstructured":"Kapoor N, Shetty S, Thomas N, Paul TV. Wilson\u2019s disease: an endocrine revelation. Indian J Endocrinol Metab. 2014;18:855\u20137.","journal-title":"Indian J Endocrinol Metab"},{"key":"1899_CR10","first-page":"249","volume":"85","author":"R Krysiak","year":"2012","unstructured":"Krysiak R, Handzlik-Orlik G, Okopien B. Endocrine symptoms as the initial manifestation of Wilson\u2019s disease. Yale J Biol Med. 2012;85:249\u201354.","journal-title":"Yale J Biol Med"},{"key":"1899_CR11","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/B978-0-444-63625-6.00013-6","volume":"142","author":"K Dzie\u017cyc","year":"2017","unstructured":"Dzie\u017cyc K, Litwin T, Cz\u0142onkowska A. Other organ involvement and clinical aspects of Wilson disease. Handb Clin Neurol. 2017;142:157\u201369.","journal-title":"Handb Clin Neurol"},{"key":"1899_CR12","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1186\/s12884-019-2641-8","volume":"19","author":"X-E Yu","year":"2019","unstructured":"Yu X-E, Pan M, Han Y-Z, Yang R-M, Wang J, Gao S. The study of Wilson disease in pregnancy management. BMC Pregnancy Childbirth. 2019;19:522.","journal-title":"BMC Pregnancy Childbirth"},{"key":"1899_CR13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jns.2003.08.007","volume":"217","author":"S Sinha","year":"2004","unstructured":"Sinha S, Taly AB, Prashanth LK, Arunodaya GR, Swamy HS. Successful pregnancies and abortions in symptomatic and asymptomatic Wilson\u2019s disease. J Neurol Sci. 2004;217:37\u201340.","journal-title":"J Neurol Sci"},{"key":"1899_CR14","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1034\/j.1600-0404.2000.90140a.x","volume":"101","author":"B Tarnacka","year":"2000","unstructured":"Tarnacka B, Rodo M, Cichy S, Cz\u0142onkowska A. Procreation ability in Wilson\u2019s disease. Acta Neurol Scand. 2000;101:395\u20138.","journal-title":"Acta Neurol Scand"},{"key":"1899_CR15","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jhep.2023.04.007","volume":"79","author":"I Mohr","year":"2023","unstructured":"Mohr I, Pfeiffenberger J, Eker E, Merle U, Poujois A, Ala A, et al. Neurological worsening in Wilson disease - clinical classification and outcome. J Hepatol. 2023;79:321\u20138.","journal-title":"J Hepatol"},{"key":"1899_CR16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3390\/biom15010051","volume":"15","author":"A Alhermi","year":"2025","unstructured":"Alhermi A, Perks H, Nigi V, Altahoo N, Atkin SL, Butler AE. The role of the liver in the pathophysiology of PCOS: A literature review. Biomolecules. 2025;15:51.","journal-title":"Biomolecules"},{"key":"1899_CR17","doi-asserted-by":"crossref","first-page":"8351","DOI":"10.3748\/wjg.v20.i26.8351","volume":"20","author":"E Vassilatou","year":"2014","unstructured":"Vassilatou E. Nonalcoholic fatty liver disease and polycystic ovary syndrome. World J Gastroenterol. 2014;20:8351\u201363.","journal-title":"World J Gastroenterol"},{"key":"1899_CR18","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12916-023-02775-0","volume":"21","author":"D Liu","year":"2023","unstructured":"Liu D, Gao X, Pan X-F, Zhou T, Zhu C, Li F, et al. The hepato-ovarian axis: genetic evidence for a causal association between non-alcoholic fatty liver disease and polycystic ovary syndrome. BMC Med. 2023;21:62.","journal-title":"BMC Med"},{"issue":"Suppl 2","key":"1899_CR19","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.21037\/atm.2019.03.30","volume":"7","author":"K Dzie\u017cyc-Jaworska","year":"2019","unstructured":"Dzie\u017cyc-Jaworska K, Litwin T, Cz\u0142onkowska A. Clinical manifestations of Wilson disease in organs other than the liver and brain. Ann Transl Med. 2019;7(Suppl 2):S62.","journal-title":"Ann Transl Med"},{"key":"1899_CR20","doi-asserted-by":"crossref","unstructured":"As P, Sf W, Km H, Se O, Mg V. M M, Adolescent polycystic ovary syndrome according to the international evidence-based guideline. BMC Med. 2020;18.","DOI":"10.1186\/s12916-020-01516-x"},{"key":"1899_CR21","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/gut.2005.087262","volume":"56","author":"U Merle","year":"2007","unstructured":"Merle U, Schaefer M, Ferenci P, Stremmel W. Clinical presentation, diagnosis and long-term outcome of Wilson\u2019s disease: a cohort study. Gut. 2007;56:115\u201320.","journal-title":"Gut"},{"key":"1899_CR22","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1002\/hep.22261","volume":"47","author":"EA Roberts","year":"2008","unstructured":"Roberts EA, Schilsky ML, American Association for Study of Liver Diseases (AASLD). Diagnosis and treatment of Wilson disease: an update. Hepatology. 2008;47:2089\u2013111.","journal-title":"Hepatology"},{"key":"1899_CR23","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S1054-139X(02)00355-5","volume":"31","author":"T Erkan","year":"2002","unstructured":"Erkan T, Aktuglu C, G\u00fclcan EM, Kutlu T, Cullu F, Apak H, et al. Wilson disease manifested primarily as amenorrhea and accompanying thrombocytopenia. J Adolesc Health. 2002;31:378\u201380.","journal-title":"J Adolesc Health"},{"key":"1899_CR24","doi-asserted-by":"crossref","first-page":"115414","DOI":"10.1016\/j.ecoenv.2023.115414","volume":"264","author":"Y Chen","year":"2023","unstructured":"Chen Y, Guan F, Wang P, Liu W, Zhang W, Sun H, et al. Copper exposure induces ovarian granulosa cell apoptosis by activating the caspase-dependent apoptosis signaling pathway and corresponding changes in MicroRNA patterns. Ecotoxicol Environ Saf. 2023;264:115414.","journal-title":"Ecotoxicol Environ Saf"},{"key":"1899_CR25","doi-asserted-by":"crossref","first-page":"114810","DOI":"10.1016\/j.ecoenv.2023.114810","volume":"255","author":"Q Wang","year":"2023","unstructured":"Wang Q, Sun Y, Zhao A, Cai X, Yu A, Xu Q, et al. High dietary copper intake induces perturbations in the gut microbiota and affects host ovarian follicle development. Ecotoxicol Environ Saf. 2023;255:114810.","journal-title":"Ecotoxicol Environ Saf"},{"key":"1899_CR26","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0015-0282(16)50004-1","volume":"47","author":"A Kaushansky","year":"1987","unstructured":"Kaushansky A, Frydman M, Kaufman H, Homburg R. Endocrine studies of the ovulatory disturbances in Wilson\u2019s disease (hepatolenticular degeneration). Fertil Steril. 1987;47:270\u20133.","journal-title":"Fertil Steril"},{"key":"1899_CR27","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1530\/eje.1.01886","volume":"152","author":"A Karagiannis","year":"2005","unstructured":"Karagiannis A, Harsoulis F. Gonadal dysfunction in systemic diseases. Eur J Endocrinol. 2005;152:501\u201313.","journal-title":"Eur J Endocrinol"},{"key":"1899_CR28","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/0002-9378(93)90163-D","volume":"169","author":"M Oga","year":"1993","unstructured":"Oga M, Matsui N, Anai T, Yoshimatsu J, Inoue I, Miyakawa I. Copper disposition of the fetus and placenta in a patient with untreated Wilson\u2019s disease. Am J Obstet Gynecol. 1993;169:196\u20138.","journal-title":"Am J Obstet Gynecol"},{"key":"1899_CR29","doi-asserted-by":"crossref","first-page":"e32326","DOI":"10.1097\/MD.0000000000032326","volume":"101","author":"N Hancerliogullari","year":"2022","unstructured":"Hancerliogullari N, Tokmak A, Guney G, Pekcan MK, Koc EM, Candar T, et al. Serum calprotectin levels as markers of inflammation, insulin resistance and hyperandrogenism in women with polycystic ovary syndrome. Med (Baltim). 2022;101:e32326.","journal-title":"Med (Baltim)"},{"key":"1899_CR30","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1515\/jpem-2022-0455","volume":"36","author":"C Unlu","year":"2023","unstructured":"Unlu C, Guney G, Tugrul Ersak D, Kosem A, Tarlan N, Tokmak A. Evaluation of serum telomerase activity in normal-weight young girls with polycystic ovary syndrome and its relation to metabolic parameters. J Pediatr Endocrinol Metab. 2023;36:283\u20139.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"1899_CR31","first-page":"61","volume":"25","author":"R Krysiak","year":"2008","unstructured":"Krysiak R, Okopie\u0144 B. [Hyperprolactinaemia\u2013like symptoms in Wilson\u2019s disease]. Pol Merkur Lekarski. 2008;25:61\u20133.","journal-title":"Pol Merkur Lekarski"},{"key":"1899_CR32","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/jhbp.812","volume":"28","author":"MC Das","year":"2021","unstructured":"Das MC, Sen Sarma M, Srivastava A, Yachha SK, Poddar U. Effect of chelation therapy in pediatric Wilson\u2019s disease: liver and endoscopic outcome. J Hepatobiliary Pancreat Sci. 2021;28:336\u201345.","journal-title":"J Hepatobiliary Pancreat Sci"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-025-01899-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-025-01899-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-025-01899-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T03:20:31Z","timestamp":1742786431000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-025-01899-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,24]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1899"],"URL":"https:\/\/doi.org\/10.1186\/s12902-025-01899-z","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,24]]},"assertion":[{"value":"5 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study adhered to the tenets of the Declaration of Helsinki. This study was approved by Medical Ethics Committee of the Affiliated Hospital of the Neurology Institute in Anhui University of Chinese Medicine (Approval Number: 2023-SYSFYSY-31), and all patients gave written informed consent before participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"78"}}